This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The developer productivity metrics that matter most The reason we believe this is that we are working with 20 tech, finance, and pharmaceutical companies that are doing it. Developer velocity index benchmarking. So, it’s complicated. But we believe it can be done. The results are not definitive, but they are promising.
Nowhere is competitive benchmarking more important than in the global pharmaceutical industry, where the process for developing and releasing a new drug is complex, high-risk, and requires significant effort and resources. Bonus: Download our guide on competitive benchmarking tactics for pharmaceutical companies.
Nowhere is competitive benchmarking more important than in the global pharmaceutical industry, where the process for developing and releasing a new drug is complex, high-risk, and requires significant effort and resources. Bonus: Download our guide on competitive benchmarking tactics for pharmaceutical companies.
The COVID-19 pandemic has ushered in a seismic shift in the pharmaceutical industry. How Pharmaceutical Market Research Is Changing Historically, market research methods in the pharmaceutical industry involved relying on historical datasets and manually searching for information from incomplete and disparate sources.
We’ll analyze patient decision journey clues that OTC brands and pharmaceutical companies need to tune into, as well as how to spot them here. No matter what the cause, it’s critical for OTC brands and pharmaceutical companies to locate this intel to better inform their efforts. Competitor Landscape.
The pharmaceutical industry is undergoing a transformation in the way new drugs are introduced into the market. Apparently, it is extremely important for pharmaceutical manufacturers to nail the drug launch! This is one of the ways pharmaceutical manufacturers can differentiate their products. So, how do you do it?
Axial: The Strategic Backbone for Bold Ambition 2030 An overview of the Axial program At the heart of AstraZeneca’s Bold Ambition 2030 lies “Axial”, an ambitious initiative to modernize its operations and propel the pharmaceutical giant toward industry leadership.
Educational components designed to share projected efficacy based on historical vaccination benchmarks? And as the months wore on , even though the pharmaceutical companies pledged not to rush the vaccine , the conversation bec am e progressively more nuanced and conspiratorial. .
These products include many different types of additives from transportation-related fluids like engine oils to personal care products, pharmaceuticals and medical devices Since 2011, Lubrizol has been a subsidiary of Berkshire Hathaway. It generated $7 billion in revenue and has an employee headcount of approximately 8,300 people globally.
Clinical Pipelines and Drug Developments – Assessing the pipeline of pharmaceutical and biotechnology companies by analyzing clinical trials to gauge the potential success of new drugs or therapies in development.
Identifying your competitors is important in itself for many reasons, such as being able to target their customer base, or benchmarking your offering. If you are a pharmaceutical company and your customers are hospitals, then yes, you are both in healthcare. Understand your competitors.
2 Next, we grouped pharmaceutical sponsors/collaborators by their Scrip 100 industry rankings into two groups: top 20 pharma and all other pharma. Assess and benchmark enrollment timing. Our initial analysis disclosed some emerging trends in IO modalities and trial locations. Obtain details on competitor clinical trial locations.
Healthcare reports, or healthcare reporting, are a data-driven means of benchmarking the performance of specific processes or functions within a healthcare institution, with the primary aim of increasing efficiency, reducing errors, and optimizing healthcare metrics. Explore our 14-day free trial & benefit from great healthcare reports!
On a more serious note, some of the exciting work that we are working on for our larger clients includes: Robotic Process Automation (RPA) for spend management, AI based constant supplier risk monitoring, and benchmarking suppliers on newer areas such as their sustainability and innovation practices. .
Dan Fitzgerald: In terms of clarity and the markets that we support today as you outlined in your intro, one of our brands serves the direct to pharmaceutical and life sciences brands and therapeutics with a very progressive technology-agile research platform. And how are you addressing it? [00:07:43]. And time is the precious asset.
Under these programs, “prescription drug spending accounts for a significant portion of national pharmaceutical spending, which totaled $577 billion in 2021, and supply-chain complexity has complicated efforts to track the flow of these dollars.” So maybe the PBMs are to blame.
For macro topics or industry updates, AlphaSense’s automated and customizable real-time alerts help you personalize your benchmarking process and ensure you are the first to know of anything with the potential to impact your strategy.
Best For: Contify is best suited for mid to large-sized companies across industries—pharmaceuticals, IT, consulting, and financial services, and more. It enables a granular understanding of competitive landscapes, customer shifts, and sector-specific trends.
When benchmarked against peers in the industry, Raytheon’s margin movement was quite volatile this quarter. By segment: Pharmaceutical margins declined from 43.8% The lowered guidance reflects softer results for Intelligence & Space and Missiles & Defense. The CFO provides insights into why that was the case: .
More specifically, next-gen offerings from Dell Technologies provide 8-10x performance improvements according to MLCommons ® MLPerf™ benchmarks. MLCommons MLPerf Results For benchmarking, the MLCommons updated version 3.0, MLCommons MLPerf Results For benchmarking, the MLCommons updated version 3.0,
Those LLMs are also achieving the kind of increased accuracy scores on the MMLU benchmark leaderboard that have become synonymous with the version upgrade cycles we are all accustomed to with SaaS product releases like clockwork. Yes, you heard that right!
Sustainability Initiatives Companies voluntarily release data on their environmental, social, and governance (ESG) practices to highlight their performance on various issues or adherence to specific sustainability reporting guidelines and benchmarks. These reports frequently help companies attract and retain customers and investors.
Sustainability Initiatives Companies voluntarily release data on their environmental, social, and governance (ESG) practices to highlight their performance on various issues or adherence to specific sustainability reporting guidelines and benchmarks. These reports frequently help companies attract and retain customers and investors.
Specifically, experts note the co-leaders of Trumps Department of Government Efficiency, Elon Musk and Vivek Ramaswamy, are pushing for greater speed and efficiency in pharmaceutical regulation, while RFK Jr., In addition, the slate of nominees has sent contradictory signals about drug regulation. RFK has] remarked on firing a lot of staff.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content